The autism spectrum disorder therapeutics market was valued at USD 2.68 billion by 2017, growing with 3.4% CAGR during the forecast period, 2018-2025
Autism spectrum disorder includes a class of neuro-developmental disabilities. Some of the prominent disorders that come under the umbrella term of autism spectrum disorder are pervasive personality disorder-not otherwise specified, Asperger’s syndrome, and autism. Autism spectrum disorder therapeutics concerns with various treatment options such as behavioral therapy, which is usually considered as the first-line treatment. Patients are also given pharmacological therapies to help them function properly in their daily lives.
Download Sample of This Strategic Report-https://www.kennethresearch.com/sample-request-10294048
Autism spectrum disorder therapeutics companies are observed to continuously introduce innovative solutions in the global market after receiving approval from regulatory authorities. In April 2019, Finch Therapeutics Group, a US developer of microbial therapies, received FDA’s Fast Track designation for its Full-Spectrum Microbiota therapy. According to the company, the therapy is aimed at treating autism spectrum disorder in children.
The growing number of autism patients is anticipated to increase the demand for autism spectrum disorder therapeutics. Companies are coming up with various novel products and have a number of drugs in the pipeline for autism treatment. Moreover, there has been a rise in the manufacture of generic pharmaceutical products used to treat autism. All of these factors are expected to push the growth of the global autism spectrum disorder therapeutics market. In addition, companies are investing heavily in research and development to introduce new products in the global market. However, tight regulations and policies associated with product approval are foretold to pose a challenge to players operating in the global autism spectrum disorder therapeutics market.
Drug Type Takeaway
The segment of insomnia drugs is projected to exhibit robust growth in the global autism spectrum disorder therapeutics market. In April 2019, the FDA announced that it will require certain prescription insomnia medicine manufacturers to issue a new boxed warning. The announcement comes after the reporting of several cases of deaths and serious injuries caused due to complex sleep behaviors after taking the medicines. Among indication segments, insomnia could secure a significant share of the global market. Analysts expect hospital pharmacies to collect a leading share of the global market, among distribution channels.
Download Sample of This Strategic Report- https://www.kennethresearch.com/sample-request-10294048
Regionally, North America is forecast to show healthier growth in the global autism spectrum disorder therapeutics market because of the rising awareness about autism, increasing incidence of the disorder, and new product development. Europe could be another high-growth regional market gaining from the increase in research and development activities and rising number of autism awareness programs.
The global autism spectrum disorder therapeutics market witnesses the presence of top players such as Actavis, Inc., Curemark LLC, Janssen Pharmaceuticals, Inc., Otsuka Holdings Co., Ltd., Pediatric BioScience, Inc., Teva Pharmaceutical Industries Ltd., Mylan Pharmaceuticals, Inc., Pfizer Inc., Novartis AG, Bristol-Myers Squibb, Merck & Co., and Par Sterile Products, LLC.
The market size and forecast for each segment and sub-segments has been considered as below:
Request For Full Report- https://www.kennethresearch.com/sample-request-10294048
Historical Year – 2014 & 2016
Base Year – 2017
Estimated Year – 2018
Projected Year – 2025
Traders, Distributors, and Suppliers
Government and Regional Agencies
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY DRUG CLASS
Selective Serotonin Reuptake Inhibitors
MARKET, BY INDICATION
Hyperactivity and Inattention
MARKET, BY DISTRIBUTION CHANNEL
MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of the World
Middle East and Africa
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation
Name: Kenneth research
Phone: +1 313 462 0609
- Automotive Door Latch Market Expected to Grow at CAGR of 6.4% by 2027|Aisin Seiki, Mitsui Mining & Smelting - July 31, 2021
- Diesel Exhaust Fluid (DEF) Market To Expand With Growing Concern For Vehicular Emissions Amongst Various Nations By A CAGR of Around 10% Throughout 2020-2028 - July 31, 2021
- Light Electric Aircraft Market Anticipated to Evince at a CAGR of 4.5% by 2027 | Electric Aircraft, DigiSky Srl, Alisport Srl - July 31, 2021